1-26911972-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021969.3(NR0B2):c.647G>A(p.Arg216His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000867 in 1,614,226 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R216C) has been classified as Uncertain significance.
Frequency
Consequence
NM_021969.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NR0B2 | NM_021969.3 | c.647G>A | p.Arg216His | missense_variant | 2/2 | ENST00000254227.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NR0B2 | ENST00000254227.4 | c.647G>A | p.Arg216His | missense_variant | 2/2 | 1 | NM_021969.3 | P1 | |
NUDC | ENST00000435827.6 | c.93+737C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251450Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135900
GnomAD4 exome AF: 0.0000896 AC: 131AN: 1461884Hom.: 1 Cov.: 32 AF XY: 0.0000853 AC XY: 62AN XY: 727240
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152342Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74486
ClinVar
Submissions by phenotype
NR0B2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 18, 2023 | The NR0B2 c.647G>A variant is predicted to result in the amino acid substitution p.Arg216His. This variant was previously reported in an individual with hypertriglyceridemia (Matsunaga et al. 2020. PubMed ID: 32115487). This variant was also described in an individual with mild obesity; however, the authors suggested that it may be a benign polymorphism (Nishigori et al. 2001. PubMed ID: 11136233). Additionally, several in vitro studies indicated that protein with the p.Arg216His change functioned similar to control (Sanyal et al. 2002. PubMed ID: 11705994). This variant is reported in 0.040% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at